Search Results for: MAPK8

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
JUND JunD proto-oncogene, AP-1 transcription factor subunit
  • Estrogen-dependent gene expression
  • NGF-stimulated transcription
  • NGF-stimulated transcription
NFE2 nuclear factor, erythroid 2
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Factors involved in megakaryocyte development and platelet production
  • Factors involved in megakaryocyte development and platelet production
NR4A1 nuclear receptor subfamily 4 group A member 1
  • AKT phosphorylates targets in the nucleus
  • Nuclear Receptor transcription pathway
  • Constitutive Signaling by AKT1 E17K in Cancer
SPI1 Spi-1 proto-oncogene
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Acute myeloid leukemia (AML)
TNFSF11 TNF superfamily member 11
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Lenalidomide
  • AMGN-0007
  • Denosumab
  • Thiocolchicoside
  • Osteopetrosis, including: Osteopetrosis, severe neonatal or infantile forms; Osteopetrosis, intermediate forms; Osteopetrosis with renal tubular acidosis; Osteopetrosis, late-onset form type 1; Osteopetrosis, late-onset form type 2; Osteopetrosis, osteoclast poor
WWOX WW domain containing oxidoreductase
  • Nuclear signaling by ERBB4
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Activation of the TFAP2 (AP-2) family of transcription factors
AIMP1 aminoacyl tRNA synthetase complex interacting multifunctional protein 1
  • Selenoamino acid metabolism
  • Cytosolic tRNA aminoacylation
  • Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
BMF Bcl2 modifying factor
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Activation of BMF and translocation to mitochondria
CAMP cathelicidin antimicrobial peptide
  • Neutrophil degranulation
  • Antimicrobial peptides
  • Selenocysteine
DUSP1 dual specificity phosphatase 1
  • RAF-independent MAPK1/3 activation
  • Negative regulation of MAPK pathway
GARS1 glycyl-tRNA synthetase 1
  • Cytosolic tRNA aminoacylation
  • Mitochondrial tRNA aminoacylation
  • Glycine
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Distal hereditary motor neuropathies (dHMN)
GUCY1A1 guanylate cyclase 1 soluble subunit alpha 1
  • Nitric oxide stimulates guanylate cyclase
  • Smooth Muscle Contraction
KRT8 keratin 8
  • Keratinization
  • Formation of the cornified envelope
  • Tenecteplase
  • Lanoteplase
  • Copper
RAD18 RAD18 E3 ubiquitin protein ligase
  • Recognition of DNA damage by PCNA-containing replication complex
  • E3 ubiquitin ligases ubiquitinate target proteins
RET ret proto-oncogene
  • RAF/MAP kinase cascade
  • RET signaling
  • Sorafenib
  • 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • Vandetanib
  • Cabozantinib
  • Regorafenib
  • Ponatinib
  • Lenvatinib
  • Fostamatinib
  • Amuvatinib
  • Selpercatinib
  • Pralsetinib
  • Hirschsprung disease (HD)
  • Renal agenesis and Renal adysplasia
  • Thyroid cancer
  • Congenital central hypoventilation syndrome (CCHS)
SPAG9 sperm associated antigen 9
  • Myogenesis
  • Myogenesis
BMPR2 bone morphogenetic protein receptor type 2
  • Signaling by BMP
  • Dibotermin alfa
  • Fostamatinib
CCDC88C coiled-coil domain containing 88C
  • Negative regulation of TCF-dependent signaling by DVL-interacting proteins
EEF2K eukaryotic elongation factor 2 kinase
  • mTORC1-mediated signalling
ELP1 elongator acetyltransferase complex subunit 1
  • HATs acetylate histones

Page 5 out of 8 pages